 | • レポートコード：QYR9ST00997 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のHIV薬市場について調査・分析し、以下の構成でお届け致します。HIV薬の種類別には、マルチクラスコンビネーション製品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、侵入阻害剤-CCR5共受容体拮抗薬、HIVインテグラーゼ鎖転移阻害剤に、用途別には、病院薬局、小売薬局、オンライン薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別HIV薬売上データ ・地域別HIV薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別HIV薬市場規模：マルチクラスコンビネーション製品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、侵入阻害剤-CCR5共受容体拮抗薬、HIVインテグラーゼ鎖転移阻害剤 ・用途別HIV薬市場規模：病院薬局、小売薬局、オンライン薬局、その他 ・主要メーカーの企業情報：Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、Johnson & Johnson、Merck ・HIV薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
The global HIV Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the HIV Drugs market based on company, product type, end user and key regions.
This report studies the global market size of HIV Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of HIV Drugs in these regions.
This research report categorizes the global HIV Drugs market by top players/brands, region, type and end user. This report also studies the global HIV Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Market size by Product
Multi-Class Combination Products
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Entry Inhibitors – CCR5 Co-Receptor Antagonist
HIV Integrase Strand Transfer Inhibitors
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global HIV Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of HIV Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global HIV Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of HIV Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of HIV Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of HIV Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 HIV Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global HIV Drugs Market Size Growth Rate by Product
1.4.2 Multi-Class Combination Products
1.4.3 Nucleoside Reverse Transcriptase Inhibitors
1.4.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.4.5 Protease Inhibitors
1.4.6 Fusion Inhibitors
1.4.7 Entry Inhibitors – CCR5 Co-Receptor Antagonist
1.4.8 HIV Integrase Strand Transfer Inhibitors
1.5 Market by End User
1.5.1 Global HIV Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global HIV Drugs Market Size
2.1.1 Global HIV Drugs Revenue 2014-2025
2.1.2 Global HIV Drugs Sales 2014-2025
2.2 HIV Drugs Growth Rate by Regions
2.2.1 Global HIV Drugs Sales by Regions
2.2.2 Global HIV Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 HIV Drugs Sales by Manufacturers
3.1.1 HIV Drugs Sales by Manufacturers
3.1.2 HIV Drugs Sales Market Share by Manufacturers
3.1.3 Global HIV Drugs Market Concentration Ratio (CR5 and HHI)
3.2 HIV Drugs Revenue by Manufacturers
3.2.1 HIV Drugs Revenue by Manufacturers (2014-2019)
3.2.2 HIV Drugs Revenue Share by Manufacturers (2014-2019)
3.3 HIV Drugs Price by Manufacturers
3.4 HIV Drugs Manufacturing Base Distribution, Product Types
3.4.1 HIV Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HIV Drugs Product Type
3.4.3 Date of International Manufacturers Enter into HIV Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global HIV Drugs Sales by Product
4.2 Global HIV Drugs Revenue by Product
4.3 HIV Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global HIV Drugs Breakdown Data by End User
6 North America
6.1 North America HIV Drugs by Countries
6.1.1 North America HIV Drugs Sales by Countries
6.1.2 North America HIV Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America HIV Drugs by Product
6.3 North America HIV Drugs by End User
7 Europe
7.1 Europe HIV Drugs by Countries
7.1.1 Europe HIV Drugs Sales by Countries
7.1.2 Europe HIV Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe HIV Drugs by Product
7.3 Europe HIV Drugs by End User
8 Asia Pacific
8.1 Asia Pacific HIV Drugs by Countries
8.1.1 Asia Pacific HIV Drugs Sales by Countries
8.1.2 Asia Pacific HIV Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific HIV Drugs by Product
8.3 Asia Pacific HIV Drugs by End User
9 Central & South America
9.1 Central & South America HIV Drugs by Countries
9.1.1 Central & South America HIV Drugs Sales by Countries
9.1.2 Central & South America HIV Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America HIV Drugs by Product
9.3 Central & South America HIV Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa HIV Drugs by Countries
10.1.1 Middle East and Africa HIV Drugs Sales by Countries
10.1.2 Middle East and Africa HIV Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa HIV Drugs by Product
10.3 Middle East and Africa HIV Drugs by End User
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Company Business Overview
11.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bristol-Myers Squibb HIV Drugs Products Offered
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Company Business Overview
11.2.3 Gilead Sciences HIV Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Gilead Sciences HIV Drugs Products Offered
11.2.5 Gilead Sciences Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline HIV Drugs Products Offered
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson HIV Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson & Johnson HIV Drugs Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Company Business Overview
11.5.3 Merck HIV Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck HIV Drugs Products Offered
11.5.5 Merck Recent Development
12 Future Forecast
12.1 HIV Drugs Market Forecast by Regions
12.1.1 Global HIV Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global HIV Drugs Revenue Forecast by Regions 2019-2025
12.2 HIV Drugs Market Forecast by Product
12.2.1 Global HIV Drugs Sales Forecast by Product 2019-2025
12.2.2 Global HIV Drugs Revenue Forecast by Product 2019-2025
12.3 HIV Drugs Market Forecast by End User
12.4 North America HIV Drugs Forecast
12.5 Europe HIV Drugs Forecast
12.6 Asia Pacific HIV Drugs Forecast
12.7 Central & South America HIV Drugs Forecast
12.8 Middle East and Africa HIV Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 HIV Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure HIV Drugs Product Picture
Table HIV Drugs Market Segments
Table Key Manufacturers HIV Drugs Covered
Table Global HIV Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global HIV Drugs Sales Market Share by Product 2014-2025
Figure Multi-Class Combination Products Product Picture
Table Major Manufacturers of Multi-Class Combination Products
Figure Nucleoside Reverse Transcriptase Inhibitors Product Picture
Table Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Figure Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Table Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure Protease Inhibitors Product Picture
Table Major Manufacturers of Protease Inhibitors
Figure Fusion Inhibitors Product Picture
Table Major Manufacturers of Fusion Inhibitors
Figure Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
Table Major Manufacturers of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Figure HIV Integrase Strand Transfer Inhibitors Product Picture
Table Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table Global HIV Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Others
Figure HIV Drugs Report Years Considered
Figure Global HIV Drugs Market Size 2014-2025 (Million US$)
Figure Global HIV Drugs Sales 2014-2025 (K MT)
Table Global HIV Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global HIV Drugs Sales by Regions 2014-2019 (K MT)
Table Global HIV Drugs Sales Market Share by Regions 2014-2019
Figure Global HIV Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global HIV Drugs Sales Market Share by Regions
Table Global HIV Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global HIV Drugs Revenue Market Share by Regions 2014-2019
Figure Global HIV Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global HIV Drugs Revenue Market Share by Regions
Table Global HIV Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global HIV Drugs Sales Share by Manufacturers (2014-2019)
Figure Global HIV Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table HIV Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table HIV Drugs Revenue Share by Manufacturers (2014-2019)
Figure HIV Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers HIV Drugs Price (2014-2019) (USD/MT)
Table HIV Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers HIV Drugs Product Type
Table Date of International Manufacturers Enter into HIV Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global HIV Drugs Sales by Product (2014-2019) (K MT)
Table Global HIV Drugs Sales Share by Product (2014-2019)
Figure Global HIV Drugs Sales Market Share by Product (2014-2019)
Figure Global HIV Drugs Sales Market Share by Product in 2018
Table Global HIV Drugs Revenue by Product (2014-2019) (Million US$)
Table Global HIV Drugs Revenue Share by Product (2014-2019)
Figure Global HIV Drugs Revenue Market Share by Product (2014-2019)
Figure Global HIV Drugs Revenue Market Share by Product in 2018
Table HIV Drugs Price by Product 2014-2019 (USD/MT)
Table Global HIV Drugs Sales by End User (2014-2019) (K MT)
Table Global HIV Drugs Sales Share by End User (2014-2019)
Figure Global Sales HIV Drugs Market Share by End User (2014-2019)
Figure Global Sales HIV Drugs Market Share by End User in 2018
Figure North America HIV Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America HIV Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America HIV Drugs Sales by Countries (2014-2019) (K MT)
Table North America HIV Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America HIV Drugs Sales Market Share by Countries
Table North America HIV Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America HIV Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America HIV Drugs Revenue Market Share by Countries
Figure United States HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States HIV Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America HIV Drugs Sales by Product (2014-2019) (K MT)
Table North America HIV Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America HIV Drugs Market Share by Product
Table North America HIV Drugs Sales by End User (2014-2019) (K MT)
Table North America HIV Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America HIV Drugs Market Share by End User
Figure Europe HIV Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe HIV Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe HIV Drugs Sales by Countries (2014-2019) (K MT)
Table Europe HIV Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe HIV Drugs Sales Market Share by Countries
Table Europe HIV Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe HIV Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe HIV Drugs Revenue Market Share by Countries
Figure Germany HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe HIV Drugs Sales by Product (2014-2019) (K MT)
Table Europe HIV Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe HIV Drugs Market Share by Product
Table Europe HIV Drugs Sales by End User (2014-2019) (K MT)
Table Europe HIV Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe HIV Drugs Market Share by End User
Figure Asia Pacific HIV Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific HIV Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific HIV Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific HIV Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific HIV Drugs Sales Market Share by Countries
Table Asia Pacific HIV Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific HIV Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific HIV Drugs Revenue Market Share by Countries
Figure China HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific HIV Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific HIV Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific HIV Drugs Market Share by Product
Table Asia Pacific HIV Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific HIV Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific HIV Drugs Market Share by End User
Figure Central & South America HIV Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America HIV Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America HIV Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America HIV Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America HIV Drugs Sales Market Share by Countries
Table Central & South America HIV Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America HIV Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America HIV Drugs Revenue Market Share by Countries
Figure Brazil HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America HIV Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America HIV Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America HIV Drugs Market Share by Product
Table Central & South America HIV Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America HIV Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America HIV Drugs Market Share by End User
Figure Middle East and Africa HIV Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa HIV Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa HIV Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa HIV Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa HIV Drugs Sales Market Share by Countries
Table Middle East and Africa HIV Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa HIV Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa HIV Drugs Revenue Market Share by Countries
Figure GCC Countries HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa HIV Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa HIV Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa HIV Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa HIV Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa HIV Drugs Market Share by Product
Table Middle East and Africa HIV Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa HIV Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa HIV Drugs Market Share by End User
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Global HIV Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global HIV Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global HIV Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global HIV Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global HIV Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global HIV Drugs Sales Market Share Forecast by Product 2019-2025
Table Global HIV Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global HIV Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global HIV Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global HIV Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America HIV Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America HIV Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe HIV Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe HIV Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific HIV Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific HIV Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America HIV Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America HIV Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa HIV Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa HIV Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table HIV Drugs Value Chain
Table HIV Drugs Customers List
Table HIV Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場：市場規模・現状・予測 The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…- IDO阻害剤の世界市場：インサイト・予測 The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market i…
- HIV治療薬の世界市場：市場規模・現状・予測 The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.HIV spreads through fluidic e…
- mTOR阻害剤の世界市場：インサイト・予測 mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell …
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…